EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models DOI
Patrizia Porazzi,

Siena Nason,

Ziqi Yang

et al.

Cancer Cell, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Epigenetic regulation in cancer therapy: From mechanisms to clinical advances DOI Creative Commons
Lei Tao, Yue Zhou, Yuan Luo

et al.

MedComm – Oncology, Journal Year: 2024, Volume and Issue: 3(1)

Published: Jan. 4, 2024

Abstract Epigenetic regulation refers to the alteration of gene expression independent changes in DNA sequence. It involves chemical modifications such as methylation, histone and acetylation, which are regulated by a coordinated interplay various regulators ensure precise spatial temporal expression. aberrations commonly observed cancer considered hallmarks cancer. In recent years, small molecules targeting specific epigenetic have been developed demonstrating promising therapeutic potential preclinical clinical trials for treatment. this review, we summarize essential regulatory mechanisms dysfunctions involved acetylation during tumor development progression. Moreover, discuss current advances challenges therapy that target these both hematologic malignancies solid tumors. Finally, combining drugs with other therapies, including chemotherapy, radiotherapy, targeted therapy, immunotherapy, approach Overall, aim enhance understanding explore strategies based on mechanisms, ultimately advance improve patient prognosis.

Language: Английский

Citations

22

Beyond genetics: Exploring the role of epigenetic alterations in breast cancer DOI Creative Commons

Kirti S. Prabhu,

Hana Q. Sadida,

Shilpa Kuttikrishnan

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 254, P. 155174 - 155174

Published: Jan. 26, 2024

Breast cancer remains a major global health challenge. Its rising incidence is attributed to factors such as delayed diagnosis, the complexity of its subtypes, and increasing drug resistance, all contributing less-than-ideal patient outcomes. Central progression breast are epigenetic aberrations, which significantly contribute resistance emergence stem cell traits. These include alterations in DNA methylation, histone modifications, expression non-coding RNAs. Understanding these changes crucial for developing advanced management strategies despite their complexity. Investigating modifications offers potential novel diagnostic markers, more accurate prognostic indicators, identification reliable predictors treatment response. This could lead development new targeted therapies. However, this requires sustained, focused research efforts navigate challenges understanding carcinogenesis underpinnings. A deeper mechanisms can revolutionize personalized medicine. significant improvements care, including early detection, precise disease stratification, effective options.

Language: Английский

Citations

18

The Role of Chronic Inflammation in Pediatric Cancer DOI Open Access

Christine Mella,

Panogiotis Tsarouhas,

Maximillian Brockwell

et al.

Cancers, Journal Year: 2025, Volume and Issue: 17(1), P. 154 - 154

Published: Jan. 6, 2025

Inflammation plays a crucial role in wound healing and the host immune response following pathogenic invasion. However, unresolved chronic inflammation can result tissue fibrosis genetic alterations that contribute to pathogenesis of human diseases such as cancer. Recent scientific advancements exploring underlying mechanisms malignant cellular transformations cancer progression have exposed significant disparities between pediatric adult-onset cancers. For instance, cancers tend lower mutational burdens arise actively developing tissues, where cell-cycle dysregulation leads gene, chromosomal, fusion gene development not seen counterparts. As such, findings adult cannot be directly applied cancers, unique mutations inherent etiologies remain poorly understood. Here, we review processes chromosomal instability, tumor microenvironment, tumorigenesis transformation explore current therapeutic interventions maintain and/or restore inflammatory homeostasis.

Language: Английский

Citations

3

Epigenetic regulation of cancer DOI
Lorenzo Galluzzi, Sheila Spada

International review of cell and molecular biology, Journal Year: 2025, Volume and Issue: unknown, P. xiii - xvii

Published: Jan. 1, 2025

Language: Английский

Citations

3

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models DOI
Patrizia Porazzi,

Siena Nason,

Ziqi Yang

et al.

Cancer Cell, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

3